SecBot SecBot
SECBOTREPLAY Home › Report › LGND

LGND · Director files 144 for 3K shares

LIGAND PHARMACEUTICALS INC · 144 filed Nov 10, 2026 at 14:25 ET

At the news

NEUTRALIMPACT 2/10

144 filed Nov 10, 2026 at 14:25 ET

Director Jason Aryeh filed a Form 144 notice to sell 3,000 shares of Ligand Pharmaceuticals Class B common stock, with an estimated aggregate market value of approximately $960,084. The shares were acquired in 2019 via secondary market purchases. This is a relatively small sale relative to the company's $6.1B market cap and the insider's apparent holdings, and the filing signals intent to sell rather than a completed transaction.

  • Director Jason Aryeh filed Form 144 to sell 3,000 shares of Class B common stock
  • Estimated aggregate market value of the proposed sale is $960,084.19
  • Shares were acquired between May 14, 2019 and July 30, 2019 via secondary market purchases
  • The proposed sale date is November 10, 2026 on Nasdaq

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access